Bioburden after Staphylococcus aureus inoculation in type 1 diabetic rats undergoing internal fixation

Plastic and Reconstructive Surgery

Volumn 134, Issue 3, 2014, Pages

  Brown, Nga L ^a   Rose, Michael B ^a   Blueschke, Gert ^a   Cho, Eugenia H ^a   Schoenfisch, Mark H ^a   Erdmann, Detlev ^a   Klitzman, Bruce ^a,b  

^a Duke University

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOZOCIN;

ANIMAL; BACTERIAL COUNT; BONE PLATE; CHEMICALLY INDUCED; COMPLICATION; DEVICES; EVALUATION STUDY; EXPERIMENTAL DIABETES MELLITUS; FEMORAL FRACTURES; GROWTH, DEVELOPMENT AND AGING; INSULIN DEPENDENT DIABETES MELLITUS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; OSTEOSYNTHESIS; RAT; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

ANIMALS; BONE PLATES; COLONY COUNT, MICROBIAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMORAL FRACTURES; FRACTURE FIXATION, INTERNAL; MALE; RATS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOZOCIN; SURGICAL WOUND INFECTION;

EID: 84907330940     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000434     Document Type: Article

References (39)

1. U.S. Department of Health and Human Services. National diabetes fact sheet: general information and national estimates on diabetes in the United States. Available at: http://www.cdc.gov/diabetes/pubs/factsheet07.htm. Accessed September 27, 2010.
2. Botushanov NP, Orbetzova MM. Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus. Folia Med (Plovdiv) 2009;51:12-17.
3. Khazai NB, Beck GR Jr, Umpierrez GE. Diabetes and fractures: An overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009;16:435-445.
4. Schwartz AV. Diabetes mellitus: Does it affect bone? Calcif Tissue Int. 2003;73:515-519.
5. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-1429.
6. Arciola CR, An YH, Campoccia D, Donati ME, Montanaro L. Etiology of implant orthopedic infections: A survey on 1027 clinical isolates. In J Artif Organs 2005;28:1091-1100.
7. Moon HK, Han CD, Yang IH, Cha BS. Factors affecting outcome after total knee arthroplasty in patients with diabetes mellitus. Yonsei Med J. 2008;49:129-137.
8. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: Adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183-189.
9. Weinstein RA, Darouiche RO. Device-associated infections: A macroproblem that starts with microadherence. Clin Infect Dis. 2001;33:1567-1572.
10. Zalavras CG, Christensen T, Rigopoulos N, Holtom P, Patzakis MJ. Infection following operative treatment of ankle fractures. Clin Orthop Relat Res. 2009;467:1715-1720.
11. SooHoo NF, Krenek L, Eagan MJ, Gurbani B, Ko CY, Zingmond DS. Complication rates following open reduction and internal fixation of ankle fractures. J Bone Joint Surg Am. 2009;91:1042-1049.
12. SooHoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010;468:2363-2371.
13. Fang A, Hu SS, Endres N, Bradford DS. Risk factors for infection after spinal surgery. Spine (Phila Pa 1976) 2005;30:1460-1465.
14. Chen S, Anderson MV, Cheng WK, Wongworawat MD. Diabetes associated with increased surgical site infections in spinal arthrodesis. Clin Orthop Relat Res. 2009;467:1670-1673.
15. Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91:1621-1629.
16. Christensen GD, Simpson WA, Younger JJ, et al . Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22:996-1006.
17. Antoci V Jr, Adams CS, Parvizi J, et al. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycinmodified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 2008;29:4684-4690.
18. Tesch GH, Allen TJ. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 2007;12:261-266.
19. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-265.
20. Alba-Loureiro TC, Munhoz CD, Martins JO, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res. 2007;40:1037-1044.
21. Ma H, Liu G, Ding W, Wu Y, Cai L, Zhao Y. Diabetes-induced alteration of F4/80+ macrophages: A study in mice with streptozotocin-induced diabetes for a long term. J Mol Med (Berl.) 2008;86:391-400.
22. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med. 2005;22:359-370.
23. von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol. 2009;10:129-132.
24. Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J Clin Invest. 1969;48:2129-2139.
25. Le NN, Rose MB, Levinson H, Klitzman B. Implant healing in experimental animal models of diabetes. J Diabetes Sci Technol. 2011;5:605-606.
26. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117:1219-1222.
27. Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines, and growth factors in keratinocytes and dermal epithelial cells in the margin of chronic diabetic food ulcers. Wound Repair Regen. 2006;14:558-565.
28. Goren I, Müller E, Pfeilschifter J, Frank S. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: A potential role of tumor necrosis factor-alpha. Am J Pathol. 2006;168:765-777.
29. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736-1743.
30. Galiano RD, Tepper OM, Pelo CR, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol. 2004;164:1935-1947.
31. Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res. 1988;232:210-216.
32. Follak N, Klöting I, Merk H. Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats. Diabetes Metab Res Rev. 2005;21:288-296.
33. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology 2005;146:3622-3631.
34. Kasahara T, Imai S, Kojima H, et al. Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice. Bone 2010;47:617-625.
35. Azad V, Breitbart E, Al-Zube L, Yeh S, O'Connor JP, Lin SS. rhBMP-2 enhances the bone healing response in a diabetic rat segmental defect model. J Orthop Trauma 2009;23:267-276.
36. Ogasawara A, Nakajima A, Nakajima F, Goto K, Yamazaki M. Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. Bone 2008;43:832-839.
37. Roep BO. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann N Y Acad Sci. 2007;1103:1-10.
38. Mestas J, Hughes CC. Of mice and not men: Differences between mouse and human immunology. J Immunol. 2004;172:2731-2738.
39. Park S, Rich J, Hanses F, Lee JC. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun. 2009;77:1008-1014.